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Cobalamin (vitamin B12) is the anti-pernicious anaemia factor that is made exclusively by 
certain prokaryotes. It is constructed along one of the most complex biosynthetic 
pathways found in nature, involving around 30 enzymes-mediated steps. In the aerobic 
cobalamin biosynthesis pathway, the central cobalt ion of the corrin component of 
cobalamin is inserted into a comparatively late pathway intermediate called 
hydrogenobyrinic acid-a,c-diamide (HBAD) to give cobyric acid. This section of the 
pathway appears to be very sensitive to feedback inhibition and hence there is a lot of 
interest in how HBAD is made. Surprisingly, there is no structural information about the 
enzyme that makes HBAD, CobB. This enzyme takes hydrogenobyrinic acid and 
amidates the a and c side chains to give HBAD. It is thought that CobB interacts closely 
with the preceding enzyme in the pathway, CobH, which is known to bind its product, 
hydrogenobyrinic acid (HBA), very tightly. In this project, attempts have been made to 
understand the structure and function of CobH and CobB through the application of 
protein crystallisation and X-ray crystallography. It is thought that CobB may interact with 
CobH in such way as to release the product and allow its amidation. Herein, the 
Allochromatium vinosum CobH and CobB have been purified and entered into a broad 
range of different crystal screens. The interaction between the two proteins has also 
been investigated using standard biochemical techniques. Although the CobB enzyme 
was observed to be more stable than CobB from other organisms, the CobH was found 
to be prone to proteolysis. The work suggests that the structure determination of CobB 
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1.0 Biosynthesis of tetrapyrroles 
 
 
Tetrapyrroles are the large macrocyclic compounds which are categorised as the most 
abundant pigment in nature (Warren & Smith 2009) [3]. These macromolecules are 
important for living organisms as well as being involved in biochemical reactions. As the 
name suggests tetrapyrroles contain four pyrrole-derived compounds which are either 
linked in linear or cyclic form via methine bridges with exception of corrinoids that lack 
one carbon bridge in their ring system (Scott & Roessner 2002) 
 
[6]





Cyclic tetrapyrroles include porphyrins which are the most recognised class as 
molecules such as hemes and chlorophylls belong to this group. The red colour 
of blood is due to presence of heme subunits in haemoglobin protein and the 
green colour of plants, algae, and some bacteria is due to presence of 
chlorophyll. Furthermore, the other tetrapyrrole class known as porphynoids 
include naturally occurring members such as cobalamin (vitamin B12), siroheme, 
coenzyme F430, heme d1 and phytochromobilins (Warren & Smith 2009) [3]. 
 
The biosynthesis of tetrapyrroles in eukaryotes is restricted to production of heme, 








tetrapyrroles such as cobalamin, coenzyme F430 and heme d1 are produced 
as shown in figure 1 (Warren & Smith 2009) [3]. 
 
The cleavage of cyclic tetrapyrroles results in formation of linear tetrapyrroles hence 
they only contain three methane bridges. The only exceptions are corrinoids as their 
ring system don’t contain one carbon bridge between the first and fourth pyrrole ring. 
The cyclic tetrapyrroles are able to chelate variety of metal ions and this important 
property allows ions such as Fe2+, Mg2+, Co and Ni+ to enter the centre of the 
pyrrole ring (Warren & Smith 2009). The outcome of the metal ion attachment is 
formation of the tetrapyrrole family which originate from uroporphyrinogen III as 
shown in figure 1 (Dailey et al. 2013) [21]. 
 
Uroporphyrinogen III is the initial cyclic intermediate that can be converted into two 
products known as coproporphyrinogen III and precorrin-2. Coproporphyrinogen III is 
used in the synthesis of hemes, chlorophylls and bacteriochlorophylls, whereas 
precorrin-2 contributes in the production of siroheme, heme d1, coenzyme F430, and 
cobalamin (Warren & Smith 2009) [3]. 
 
The synthesis of the complex tetrapyrroles requires conversion of uroporphyrinogen 
 
III into precorrin-2 by the action of uroporphyrinogen III methyltransferase. 
Furthermore, in order to synthesise haem and chlorophyll, uroporphyrinogen III is 
decarboxylated into coproporphyrinogen III due to the activity of an enzyme 



























































Figure 1: Group of modified tetrapyrroles that are found in nature are driven from uroporphyrinogen III 
(in the centre) which is the first branch point of the pathway. Chlorophyll is the main component that 
absorbs light in photosynthetic reactions. Heme is the main requirement in oxygen and electron 
transport system as well as being the part of enzymes such as catalases and proxidases. Haem b is 
the most abundant haem that is found in the oxygen transporter proteins such as haemoglobin and 
myoglobin, heme d1 is essential in the denitrification of nitrate salts, siroheme plays an important role 
in sulphur assimilation pathway and nitrite reductases, coenzyme F430 is essential in reducing co-
enzyme M in methanogenesis and cobalamin functions as a coenzyme in variety of rearrangements, 
reductions and methylation processes (Warren & Smith 2009)[3] (Raux et al. 2000)[11] (Dailey et al. 







1.1 Introduction and Overview of Vitamin B 12 
 
 
Vitamin B12, also known as cobalamin, is a modified tetrapyrrole. The architecture of 
this macromolecule shows the presence of the central cobalt ion that contains an 
upper and lower ligand. The lower ligand of cobalamin is 5, 6-
dimethylbenzimidazole (DMB), which is attached to the corrin ring by a nucleotide 
loop. The upper ligand in biologically active forms of the nutrient is generally either 
an adenosyl or methyl group, which are covalently attached to the cobalt ion,forming 
a unique cobalt-carbon bond (Warren & Smith 2009) [3]. 
 
Cobalamin is one of the body’s essential vitamins and helps to maintain the regular 
function of the nervous system, brain and production of red blood cells. This organic 
compound is not naturally produced by humans, therefore it has to be consumed 
through diet in order to reach the optimum level that is required for the body to 
function in good health. Vitamin B12 deficiency affects the function of two 
metabolically important enzymes; methionine synthase and methyl malonyl CoA 
mutase. Changes to the function of these enzymes result in the rise of conditions 
such as pernicious anaemia, neurological disorders and other diseases that are 
associated with methionine metabolism. (Warren & Smith 2009) [3]. 
 
Plants and animals are incapable of producing cobalamin as they do not have the 
cobalamin synthesis enzymes. This fact emphasises the distinctive property of 
vitamin B12 as it is the only vitamin that is produced exclusively by bacteria or 
archaea, and not by any eukaryote. 
 
The biosynthesis of cobalamin requires several steps which are dependent on the 









peripheral methylation, ring contraction, decarboxylation, cobalt insertion, amidations, 
lower nucleotide loop assembly and attachment, and upper ligand attachment. 
 
Cobalamin is synthesised through two known routes which are referred to as the 






1.2 The Aerobic and Anaerobic Biosynthesis Pathways 
 
 
The synthesis of cobalamin20requires several enzymes which can be divided into 
two distinct routes and for this reason the genes that code for the enzymes 
contributing in aerobic pathway are given the prefix Cob while the genes of the 
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Figure 2: The image above showing the aerobic cobalamin synthesis pathway. The conversion of 
Uroporphyrinogen III to B12 is a process that is catalysed by enzymes that are responsible for the 
chain of reactions that include peripheral methylation, ring contraction, decarboxylation, cobalt 
insertion, amidation, lower nucleotide assembly and attachment of an upper ligand. The numbering of 
the carbon atoms and the order of enzymes appearance during this activity are also shown (Warren 






1.2 The Aerobic and Anaerobic Biosynthesis Pathways 
 
 
The aerobic pathway is known as the early cobalt insertion and anaerobic pathway 
is the late cobalt inclusion. However, regardless of the differences, the process of 
methylation and amidation of tetrapyrroles in both pathways are followed in the 
same order which is an indication of noticeable similarities between the two routes 





































Figure 3: The aerobic (blue) and anaerobic (red) biosynthetic of cobalamin from precorrin-2 to cobyrinic 
acid a,c- diamide. Many biosynthetic steps are predicted from sequence comparison (Moore & Warren 
2012) [7]. 
 
These pathways are distinguished by the necessity of oxygen. The late insertion 
pathway requires molecular oxygen as an essential requirement for ring 






The aerobic pathway requires five S-adenosyl-L-methionine (SAM) dependent 
methyltransferases in order to introduce six methyl groups which are categorised by 
combination of oxygen molecule. Due to the activity of an enzyme CobG acts as a 
monooxygenase as it combines oxygen with carbon 20 before ring contraction of the 
macrocycle begins. The enzyme CobG also catalyses the combination of oxygen 
also at position C20 followed by the formation of - lactone in order to produce 
precorrin-3 hydroxylactone (figure 2) which are the initial requirements for ring 
contraction (Scott & Roessner 2002) [6]. 
 
The intermediates involved in the aerobic biosynthetic pathway from 
uroporphyrinogen III to adenosylcobalamin have been determined by isolation of 
genes from Pseudomonas denitrificans and the function of the encoded 
enzymes was allocated by their catalytic activity. 
 
Moreover, specific genes encoding for proteins that are involved in the anaerobic 
biosynthesis of cobalamin have been isolated from bacteria such as Salmonella 
typhimurium, Bacillus megaterium and Propionibacterium freudenreichii (Scott & 
Roessner 2002) [6]. 
 
Unlike the aerobic pathway, the catalytic function of the anaerobic enzymes has been 
determined through experimenting a few gene products and comparison of the genome 
sequence has allowed identifying their function (Scott & Roessner 2002) [6] . 
 
One feature of cobalamin that distinguishes it from other tetrapyrroles, is the 
insertion of the central cobalt ion. The biosynthetic pathway to the production of 
adenosylcobalamin from its five carbon precursor, 5-aminolaevulinic acid (ALA) is 
divided into two main stages. The initial step is the production of uroporphyrinogen 






The second step involves conversion of uroporphyrinogen III into ring contracted 
and deacylated intermediates known as precorrin-6 which is the intermediate of the 
aerobic pathway or cobalt-precorrin 6 which is the anaerobic equivalent. 
 
1.2.1 Differences between aerobic and anaerobic pathway 
 
 
The differences between the aerobic and anaerobic pathway is reflected at a 
step following the ring contraction in which precorrin-4 is converted to precorrin-6 
in aerobic pathway and cobalt-precorrin-4 to cobalt-precorrin-6 in the anaerobic 
pathway (Santander et al. 1997) [19]. 
 
This transformation in anaerobic biosynthesis requires opening of the -lactone ring 
followed by methylation at C11, removal of acetaldehyde and methylation at C-1. 
Due to the opening of the -lactone ring oxygen is exchanged at C-27 acetate site 
which results in extrusion of acetaldehyde followed early insertion of the cobalt ion. 
However in aerobic biosynthesis the oxygen exchange step at C-27 acetate site is 
not required therefore acetic acid is extrude instead. For this reason the insertion of 
the cobalt in this pathway occurs after the ring contraction stage is complete 
(Santander et al. 1997) [19]. 
 
Moreover, in anaerobic pathway the conversion of cobalt-precorrin-6B to cobalt - 
precorrin-8 requires an intermediate step which is catalysed by the action of CbiT 
followed by CbiE (Negro et al. 2013) [20] .The bifunctional enzyme CbiT converts cobalt-
precorrin-6B to cobalt-precorrin-7 by decarboxylating and methylating carbon- 
 
15. This event is followed up by the action of CbiE which methylates cobalt-
precorrin-7 at carbon-5 in order to produce cobalt-precorrin-8 (Negro et al. 2013) 
 
[20].The conversion of precorrin-6B to precorrin-8 in aerobic pathway is a more straight 






The transformation of the named intermediates to adenosylcobalamin is one of the 
main differences that distinguishes aerobic pathway from anaerobic pathway. 
(Scott & Roessner 2002) [6]. 
 
1.3 Synthesis of precorrin-8, the substrate for CobH 
 
 
The intermediates involved in the aerobic biosynthesis are classified as “precorrin-n” 
in which (n) specifies the number of methyl groups that are attached to the 
framework at each step of the pathway shown in figure 2. 
 
The first two methyl transfers are catalysed by a homodimer known as S-adenosyl-L-
methionine uroporphyrinogen III methyltransferase (SUMT or CobA) shown in figure 
 
1. This enzyme transfers methyl groups donated by S-adenosyl-L-methionine (SAM) 
to position C2 and C7 of uroporphyrinogen III, producing precorrin-2. This reaction 
can be inhibited by a competitive inhibitor known as S-adenosyl-L-homocysteine 
 
(SAH), the secondary product of this methylation reaction (Warren & Smith 2009) 
[3]. CobI methylates precorrin-2 at position C20, producing precorrin-3A which is a 
 
substrate for the monooxygenase enzyme CobG. This enzyme generates tertiary 
alcohol at C20 and forms a -lactone with acetate sidechain on ring A (precorrin-3B). 
 
Due to the presence of tertiary alcohol at C20 of this intermediate, precorrin-3B is set 
to catalyse ring contraction by a SAM dependant precorrin-3B methyltransferase 
also known as CobJ. This enzyme catalyses C17 methylation by addition of a methyl 
group from the top plane of the macrocycle unlike other methyl groups at position 
C1, C2, C7 and C12 which are located on the lower side of the corrin molecule 
(Negro et al. 2013) [20] . This particular functional property of CobJ suggests that the 
substrate of this enzyme binds the active site by orientating in the opposite direction 






methylation takes place are in an inverse orientation (Negro et al. 2013) [20]. The 
final product of CobJ activity is precorrin-4. This product is substrate for another 
methyltransferase known as CobM. This enzyme methylates precorrin-4 at position 
at C 11 of the porphyrin ring to form precorrin-5. Studies have shown that the methyl 
groups of corrin macrocycle are positioned at C12 and not C11 (Negro et al. 2013) 
[20]. This specific fact suggests that CobM is a multifunctional enzyme as it 
methylates C11 in order to allow decarboxylation of acetate side chain which is 
attached to C12. 
 
The outcome of this reaction contributes in authorizing the function of the subsequent 
enzyme (Negro et al. 2013) [20]. Further along the pathway is CobF which removes 
the methyl ketone at position C1 and then methylates the same position and for this 
reason CobF is best known as a multifunctional enzyme that contains both properties 
of deacetylase and methyltransferase (Negro et al. 2013) 
 
[20]. Both methyltransferases CobM and CobF eliminate acetyl group as acetic acid 
at position C20 and add the methyl groups at C11 and C1 position. Formation of 
precorrin-5 and precorrin-6A is the outcome of these reactions (Negro et al. 2013) 
 
[20]. Unlike other stages of cobalamin synthesis and the role of enzymes that are 
involved, CobK causes ring reduction by reducing the double bond between C18 
and C19 in presence of the reducing agent NADPH transforming precorrin-6A to 
precorrin-6B in presence of this reducing agent. 
 
CobL is a multi-functional homo-octameric enzyme which is responsible for 
methylations at C5 and C15 as well as decarboxylation of the acetate side chain in 










Data from sequence comparison between the N-terminal and the C-terminal of 
CobL has determined that the C-terminal region is most likely to take part in 
decarboxylation and methylation at C15 whereas the N-terminal region hosts the 
methyltransferase activity at C5 (Warren et al. 2002) [2]. This was subsequently 
confirmed by biochemical experiments involving dissection of the protein into 
functional N- and C- terminal domains (Deery et al. 2012 [1], Negro et al. 2013) [20]. 
 
1.4 Hydrogenobyrinic Acid (HBA) synthesis 
 
 
The subsequent step in completing the corrin macrocycle is catalysed by a 
homodimeric enzyme known as CobH, which converts precorrin-8 into 
hydrogenobyrinic acid (HBA). This transformation involves the migration of the 
methyl group attached to C-11 onto C12 through a reaction involving a 1, 5-
sigmatropic rearrangement as shown in Figure 2. 
 
CobH was initially discovered as a protein that binds hydrogenobyrinic acid very 
tightly before it was shown that the enzyme acts as the catalyst that is responsible 
for methyl group movement within precorrin-8. 
 
The movement of the methyl group has a great effect on the conjugated ʋ-system of 
the macrocycle which can be detected as the molecule changes colour from yellow 
to pink due to a visible hypochromic shift. 
 
The CobH protein has recently been crystallised and the structure reveals that CobH 
is a dimer with two independent active sites as shown in figure 4. This small enzyme 
has a subunit molecular mass of around 23 kDa with a highly conserved histidine 
residue that is found in the active site. Previous studies have shown that CobH has 








ratio of 2 protein monomers per 1 molecule of HBA (Thibaut et al. 1992)[4] (Deery et 
 























Figure 4: Crystal structure of CobH bound to two molecules of HBA which are located into two 




1.5 Hydrogenobyrinic acid a, c-diamide synthesis 
 
 
The enzyme responsible for the conversion of HBA into HBAD is called CobB and 
was first identified in P denitrificans Biochemical characterisation has shown the 
protein to be a homodimer with a molecular mass of 45 kDa in solution. This enzyme 
is responsible for amidation of the a and c side chains of HBA in order to synthesise 
hydrogenobyrinic acid a,c-diamide. 
 
Generating HBAD is an energy consuming process involving the consumption of 
Mg2+-ATP for the transfer of the amido group from each of the two glutamine 
molecules to the acetyl side chain of hydrogenobyrinic acid. 
 
The first amide group is transferred to the side chain of carbon C2 (a-chain) and the 







figure 5. The product, hydrogenobyrinic acid a,c-diamide (HBAD), is the substrate 
 




















Precorrin-8 (PC8)  Hydrogenobyrinic acid (HBA)  Hydrogenobyrinic acid a, c diamide (HBAD) 
 
 
Figure 5 : A step in the aerobic (late cobalt insertion) pathway of adenosylcobalamin biosynthesis which shows 
how CobH catalyses the conversion of precorrin-8 to hydrogenobyrinic acid (HBA) by methyl migration from 
C11 to C12. CobB generates hydrogenobyrinic acid a,c-diamide, by amidating the a and c side chain of HBA. 




1.6 Principle of substrate channelling 
 
 
The principle of substrate channelling defines a mechanistic process in which the 
intermediate of a reaction is directly delivered from the active site of one enzyme 
to the active site of a second enzyme without the need of prior dissociation into the 
solvent. Enzyme channels are referred to as molecular gates which are able to 
control the transport of substrates through biomolecular systems by monitoring the 
individual substances before allowing or denying their access to specific sites or 
within the macromolecules by reversibly switching between open and closed 
conformation. As a result of this, the product from one active site is actively or 






Metabolic channelling aligns the catalytic sites of the enzymes in order to 
facilitate the rapid movement of intermediates, decreases their transmission time 
and prevents their loss after diffusing into the surrounding environment. 
 
Substrate channelling can occur in multifunctional enzymes, tightly bound multi 
enzyme complexes, or transient enzyme complexes. 
 
Aims and objectives 
 
 
The aim of this project is to investigate the conversion of precorrin-8 into HBAD, 
focusing on how tightly bound products are released and made available for 
subsequent enzymes. It has been suggested that substrate channelling is involved in 
this step of cobalamin biosynthetic pathway. Such direct metabolite transfer from one 
enzyme to the next must involve some kind of protein-protein interactions. The 
interaction has to involve conformational change to allow the donating enzyme to 
release its product and the accepting enzyme must bind it more tightly than the 
donor. The CobB and CobH enzymes represent an excellent model system in order 
to study the molecular process. 
 
In this work both CobH and CobB from A. vinosum were used to study this process. 
Previous studies on CobBs have shown that these enzymes have difficulty with turning 
over substrate, which means that the enzyme’s catalytic efficiency is low. However, A. 
vinosum CobB was found to be most conformationally stable in comparison to the other 
studied CobBs. The greater activity of the A. vinosum CobB, coupled with its higher 
stability, suggested that this would be the best enzyme system to work with. 
 
Although the A. vinosum CobB had previously been cloned, the CobH had not been 
characterised from this bacterium. Hence, the work here also involved the cloning 






involved the use of a variety of techniques including in vivo trapping, in vitro binding 
and crystallography. 
 





2.0 Growth medium 
 
 
1.  LB/LB agar 
 
 
10 g Tryptone 
 
 
5 g Yeast extract 
 
 
5 g NaCl 
 
 
1 litre dH2O 
 
 






2.  2YT medium 
 
 
2x Yeast Extract Tryptone is a nutritionally rich growth medium which is designed for 
growth of recombinant strains E.coli. The growth is more rapid in this rich medium as 
it contains essential nutrients, growth factors that the strain requires. 
 
16 g Tryptone 
 
 
10 g Yeast extract 
 
 
5 g NaCl 
 
 















- Ampicillin at final stock concentration of 100 mg/mL 
 
 
- Chloramphenicol at final stock concentration of 34 mg/mL in ethanol 
 
 
4. Addition of glucose 
 
 
Glucose with final concertation of 20% 
 
 
2.1 Starter culture and Glycerol stock 
 
 
One colony from the transformation plate is added to 5 mL of LB containing 
ampicillin at 100 mg/mL final concentration, chloramphenicol at a final concentration 
at 34 mg/mL and 50 µL of glucose with a final concentration of 20%. The mixture is 
incubated overnight at 28 ºC shaking incubator. The glycerol stock of bacteria was 
made by resuspending 300 µL of overnight starter culture and into 700 µL of 50% 
glucose. The mixture is immediately frozen at -80 ºC. 
 
2.2 Inoculating starter culture into 1 litre LB 
 
 
The overnight starter culture was added to one litre LB as well as addition of 1 ml of 
100 mg/mL Ampicillin and 34 mg/mL Chloramphenicol. The strain is grown at 28 ºC, 
160 rpm incubator until the OD600= 0.3 is reached. The protein production was 
induced by adding 400 µL of isopropyl 1-thio-く-D – galactopyranoside (IPTG) from 
1M stock solution. The litre is incubated at 19 ºC, 160 rpm overnight. 
 
2.3 Harvesting Bacteria 
 
 
The culture was centrifuged at 4000 rpm for 20 minutes in order to allow separation 






The bacteria are resuspended in 30 ml of the binding buffer that contained 20 mM 
Tris-HCl pH 8 + 500 mM NaCl +5 mM imidazole pH 7. 
 
2.4 Protein purification 
 
2.4.1 Cell lysis by sonication 
 
 
The resuspended cells in binding buffer were used directly for protein purification. 
Transferred cells into the sonication vessel and that is surrounded by ice water. The 
Vibracell Ultrasonic processor was set for 30 seconds on 30 seconds off pulses with 
50% amplitude for 5 minutes. Once the cells were fully broken up, 50 µL of the 
protein is collected in the Eppendorf tube for SDS-PAGE. After sonication, the cells 
were centrifuged at 18000 rpm for 20 minutes and another 50 µL sample was 
collected for SDS-PAGE. 
 
2.4.2 Purification of recombinant protein using IMAC 
 
 
Steps in preparing the Nickel column: 
 
 
1. The column was prepared by loading the empty column with 5 ml of Chelating 
 
SepharoseTM and washed with buffer to remove the storage ethanol and allow the 
resin to pack. 
 
2. The column was charged by using 15 ml of charge buffer 50 mM NiSO4. 
 
 
3. Equilibrated the column by 20 ml of the binding buffer that was made up of 20 mM 
Tris-HCl pH 8 + 500 mM NaCl + 5 mM imidazole. 
 
4. It was essential to collect flow- through samples of each step so they can be 











Steps in IMAC purification: 
 
 
1. The supernatant was loaded onto the column after centrifugation. 
 
2. The first wash required 20 ml of the binding buffer that was used at the prior step, 
 
3. Wash I: 10 ml of wash buffer that contained 20 mM Tris-HCl pH 8 + 500 mM 
NaCl + 50 mM imidazole. 
 
4. Wash II: using 5 ml of wash buffer II which was made up of 20 mM TRIS-HCl pH 
8 + 500 mM NaCl + 100 mM imidazole. 
 
5. Protein elution: 5-10 ml elution buffer containing 20 mM Tris-HCl pH 8 + 500 
mM NaCl + 400 mM imidazole. 
 
6. 1 ml fractions were collected for Bradford assay test as well as SDS-PAGE. 
 
7. Regeneration of Chelaing Sepherose by 15 ml of strip buffer made of 20 mM 
Tris-HCl pH 8 + 500 mM NaCl + 100 mM EDTA. 
 
 
2.4.3 Bradford Protein Assay 
 
 
This assay depends on the dye Coomassie blue G250, which is present in the Bradford 
reagent solution , changing colour from red to blue in presence of protein, to provide a 
rough estimate quantification of protein concentration in each fraction that had been 
collected during elution. Drops of 10 µL dH2O were put on a sheet of parafilm to which 5 
µL of the Bradfor reagent solution was added and mixed thoroughly by pipetting the 
mixture up and down. Then 5 µL of each elution fraction was then added to the mixture 
















2.4.4 Buffer exchange PD10 column 
 
 
The most concentrated fractions from the Nickel column were chosen to run on a 
desalting PD10 column. The protein from prior step contains a high concentration of 
imidazole, thus applying the sample to this column allowed removing the excess salt. 
 
1. The column was equilibrated by 25 ml of the buffer that contained 20 mM 
Tris-HCl pH 8 + 100 mM NaCl 
 
2. The total volume of 2.5 ml of the sample was added to the column. 
 
3. Protein was collected by adding 3.5 ml of elution buffer containing 20 mM 







10% Acrylamide 12.5% Acrylamide 5% Acrylamide stacking gel 
separation gel  separation gel     
      
dH2O (ml) 4.7 dH2O (ml) 3.4 dH2O (ml) 3.4 
         
30% Acrylamide 5 30% Acrylamide 6.3 30% Acrylamide (ml) 1.5 
(ml)   (ml)      
      
1.5M  Tris-HCl,  pH 3.8 1.5M Tris-HCl, pH 3.8 0.5 M  Tris-HCl, pH 1.9 
8.8 (ml)   8.8 (ml)  8.8 (ml)  
       
10% SDS (ml) 1.5 10% SDS (ml) 1.5 10% SDS (ml) 0.75 
       
10% APS (ml) 0.15 10% APS (ml) 0.15 10% APS (ml) 0.075 
      
TEMED (ml) 0.01 TEMED (ml) 0.01 TEMED (ml) 0.01 




Table 1: Polyacrylamide gels were set up as outlined in above table. The gels were run at 200 volts 







1. Approximately 50 µL of the fractions that had been collected at different stages 
of the purification are mixed with 50 µL of 2 times laemmli buffer and boiled for 5 
to 10 minutes. 
 
2. The gel was securely placed into the tank and addition of 10x running buffer 
filled up the wells. 
 
3. 10 µL of individual samples were loaded into each well of the SDS-gel 
 
4. The gel was run at 200 volts for 1 hour and stained with coomassie blue stain 
 
5. The gel was destained by several washes with dH2O or overnight in dH2O on a 
rocking platform. 
 
2.5 Gel Filtration- FPLC 
 
 
This method is used for size exclusion of the protein which is purified through the 
Superdex TM 200 10/300 GL resin. 
 
The column was washed with Milli Q water or double distilled (ddH2O) and then 
equilibrated with a buffer containing 20 mM Tris-HCl pH 8 + 100 mM NaCl. Around 1.5 
ml of the most concentrated protein sample is injected into the column and 12 fractions 
were collected at the end of the run. The generated evaluation graph indicated the highly 
concentrated fragment by showing the highest absorbance peak at 280 nm 
 
The most concentrated fraction was picked to for purity check through SDS-PAGE 
before being used for crystallography. 
 
The column was then cleaned by another wash with Milli Q water and final 













2.6 HBA purification 
 
 
2.6.1 DEAE - Ion exchange chromatography (HBA –ve, DEAE +ve) 
 
 
Around 1 ml -1.5 ml of DEAE Sephadex column solution is loaded into a syringe. 
After the resin has settled, it must be equilibrated with 25 mL of 20 mM Tris-HCl pH8 
+ 100 mM NaCl in order to reach pH8 before loading the supernatant. The 
supernatant of the HBA producing culture is applied to the column and washed 
several times with increasing concentration of NaCl. This separates any impurities 
from HBA.The bright orange substrate, HBA is ready to be eluted when the 


































Figure 6: the DEAE column after applying the HBA supernatant to the resin. The separation of the 
materials takes place as the concentration of salt gradually increases. HBA elutes after the addition 







2.6.2 RP18 desalting column 
 
 
The samples had to be acidified with 0.5 M HCl to a pH below 4 after elution from 
DEAE column. The sample was then centrifuged at 18000 rpm for 20 minutes in 
order to allow separation of the impurities from the sample. 
 
RP18 column preparation 
 
Washed column with 3 ml of acetonitrile 
 
Equilibrate column with 10-15 ml of 0.1% 




Wash I:  0.1% TFA 
 
Wash II :  5% ethanol in 0.1% TFA 
 
Wash III: 10% ethanol in 0.1% TFA (around 10mls) 
 
Wash V: 20% ethanol in 0.1% TFA (collect fractions, keep adding until all HBA is 
removed) 
 
Eluted with 50% ethanol 
 





The protein was concentrated using an Amicon Ultra-4 centrifugal filter to the 
desired concentration. Approximately 1mL of purified CobB with initial concentration 
of 2.5 mg/mL was concentrated to 6 mg/mL by continuous centrifugation. The 
sample is then used for carrying out the crystallisation process. 
 
Conditions were screened using a structural screen 1 and 2 kit from Molecular 
dimensions. The hanging drop vapour diffusion method was used, in which 500 µL 






Each well was sealed with a glass cover slip that had two drops on in order to 
examine the crystallisation process of protein in presence and absence of the 
substrate. The ratio of 5:1 of HBA is added to the protein. For this purpose, 2 µL 
of the well condition was added on top of 1 µL of 6 mg/ mL protein + 1 µL of HBA 
(3.53mM) is put on each glass covers. 
 
Orange drop – HBA or HBAD (1 µL of 3.52 mM stock) + protein (1µL of 6 mg/mL)  
 
 
White drop – Protein only: 2 µL CobB (6 mg/mL) 
 
 
For enhancing the chances of crystal formation the protein of interest is mixed with 
other Co-factors which include ATP, magnesium and glutamine. 
 
Magnesium 10x protein cencentration 
ATP 5x protein concentration 


























Figure 7: The two-dimensional phase diagram shows the changes in protein concentration against 
the precipitating agent concentration. The solubility curve divides the changes in state of protein 
concentration into two regions known as unsaturated and supersaturated region. The supersaturated 






2.8 Thrombin Cleavage 
 
10x Thrombin cleavage 1x Thrombin cleavage 
  
200 mM Tris-HCl pH 8.4 20 mM Tris-HCl pH 8.4 
1.5 M NaCl 150 mM NaCl 





Depending on the concentration of protein 1 unit of thrombin is used for 1 mg of 
protein. The mixture could either be kept at 25 ºC room temperature or kept in the 
fridge overnight (4 ºC). 
 
Once the His-tag was cleaved from the protein it had to be filtered through Nickel 
column. This ensures that the His-tag is fully cleaved as the protein was eluted 
straight after being loaded on to the column. Then the sample was also run through 
PD10 column to further purify the protein and make sure that it is in the right buffer 







Plasmid Description Source 
   
pET3a-AIGJFMKL Contains all genes that code for ED 
 PC8  
   
pET3a-AIGJFMKL+ His-tagged His-tagged cobHAlvin +HBA BJ 
cobHAlvin   
pET14b-AlvinCobB His-tagged cobBAlvin BJ 
pET3a-AIGJFMKLH+ His-tagged His-tagged cobBAlvin +HBAD BJ 













Bacterial strain  
 
E.coli  strain Genotype /phenotype Source 
   
JM109 endA1, recA1, gyrA96, thi, Promega 
 hsdR17 (rk–,  
 mk+), relA1, supE44, 〉( lac-  
 proAB),  






High-Efficiency Protein Promega   
 Expression from Gene with   
  T7 Promoter and Ribosome   
  Binding Site        
  Genotype :        
  F–, ompT, hsdSB (rB–, mB–      
  ), dcm, gal, そ(DE3), pLysS,      
  Cmr.        
            
 PCR amplification of CobH gene        
          
    A  B   C  
 PCR   -  +     
          
 FSHF buffer x10   5  5   5  
         
 DMSO   0  (1 µl)up to 5  4  
     µl    
          
 Forward primer @ 10  µM   2  2   2  
          
 Reverse primer @ 10  µM   2  2   2  
          
 dNTPS @ 2 mM   5  5   5  
         
 Template (genomic DNA diluted 1:100)  1  1   1  
         
 H2O   34.5  (33.5) up to  30.5  
     50 µl    
          
        34  
        Bahareh Jafari 
           
 FSHF enzyme (no1 in freezer)  0.5 0.5  0.5   
           
  2 mins at 96˚C        
           
  30 s at 96˚C        
 30 cycles of 30 s at 55˚C        
          
  x min at 72˚C (x = 1000 bp/min) 40 s @72˚C      
           
            





Agarose Gel for separating DNA from buffer 
 
 
PCR samples are loaded by the following order shown below and left for an hour at 
120V in order to allow the samples to separate in size as it reaches the end of 
agarose gel. 
 
Marker A+2 µl of (x 5) B+2 µl of (x 5) C+ 2 µl of (x 5) 
 loading Buffer loading buffer loading buffer 
    
5 µL 60 µL 60 µL 60 µL 
    
 
 
As the run on the agarose gel ends, the appropriate bands that correspond to the 
expected size of DNA are required to be cut out of the gel.The cobH band for the 
cloning experiment was cut at the band that gave 4149 bp. The sample is placed 
















2.9.1 Creating initial vector and insert 
 
 
pET3a-AIGJFMKL ( PC8 genes) 
 
pET3a-cobH Alvin  (non-His tagged) 
pET14b- cobH Alvin  (His-tagged) 
 
The initial step was to create two plasmids; one containing all the genes up to and 
including cobH and His-tagging the cobH Alvin and one that only expressed the CobH 
enzyme. Based on the position of Histag appropriate restriction enzymes were 
chosen to cut the plasmids. The insert pET3a- cobH Alvin was cut by XbaI and EcoRI 
and the same restriction enzymes were used to cut pET14b- cobH Alvin that 
contained His-tag. The vector pET3a-AIGJFMKL was cut by SpeI and EcoRI. 
 
During ligation, SpeI and XbaI restriction sites, both lose nucleotide bases from each 
site which allows sealing and locking of the plasmid. The JM109 competent cell was 
transformed with the ligation sample onto LB + agar + glucose and Ampicillin plate. 
 
2.9.2 Cloning pET3a-AIGJFMKL + His-tagged cobH Alvin 
 
Designing a plasmid that contained genes coding for His-tagged cobH Alvin required 
the vector fragment that expressed all genes for PC8 and an insert that expressed 
His-tagged cobH Alvin. The vector was cut with restriction enzymes EcoRI and SpeI 
and the insert was cut with XbaI and EcoRI. 
 
2.9.3 Cloning pET3a-AIGJFMKLH Alvin  and pET14b- cobB Alvin 
 
The aim of this cloning is to create a plasmid that co-expresses genes that code for 
the production of HBA as well as the genes that code for HBAD production. In order 
to achieve this, appropriate restriction enzymes are selected so a vector and an 






plasmid. The vector fragment was created by cutting the pET3a-AIGJFMKLH using 
restriction enzymes XbaI and SpeI whereas the insert pET14b-cobB Alvin was 
formed by restriction enzymes XbaI and EcoRI. The ligated fragments will form a 
plasmid that contains genes coding for CobH and the succeeding enzyme CobB. 
The vector of this plasmid contains all the genes that code for precorrin-8 and the 
enzyme cobH that catalyses the production of HBA. However, the insert of interest is 
only expressing the His-tagged CobB that in combination with the prior genes in the 
vector catalyses the conversion of HBA to HBAD. After ligation, a starter culture is 
made using a single colony from the agar plate and then grown in 5 ml LB at 28 °C. 
The bacterial DNA was extracted from the bacterial pellets by QIAprep spin Mini-
prep kit. 
 
2.9.4 Miniprep QIAprep Spin Miniprep Kit Using a Microcentrifuge 
 
 
The DNA of the bacterial strain is isolated by using the QIAprep spin miniprep kit. 
 
The eluted DNA is then used for the process of restriction digest. 
 
 
2.9.5 Restriction digests and agarose gels 
 
 
In order to test the vector and insert of interest the purified miniprep DNA of both 




In one Eppendorf tube: 
 
Miniprep DNA 5 µL (pET3a –CobB Alvin or pET14b-Alvin CobH) 
 
Buffer NEB2.1 (x 10) 1 µL 
 
Restriction enzyme EcoRI 0.5 µL 
 
Restriction enzyme NdeI 0.5 µL 
 






2.9.6 DNA agarose gel electrophoresis 
 
 
0.8 grammes of Agarose powder was weighed and put into the 250 ml conical flask. 
Then 80 ml of 1 x TAE buffer was added and mixed with the agarose. The mixture 
was then fully dissolved and its temperature was reduced by gently swirling the 
conical flask under the tap water. One drop of ethidium bromide (10 mg/ml) was 
added following by a gentle swirl to mix. The gel was poured into the tray and the 
comb was inserted. The gel was left to set for 30 minutes. 
 
Loading the agarose gel 
 
 
5 µL of the DNA marker 
 
 
Added 2 µL of DNA loading buffer (x5) to each digest (mixed 
thoroughly) The sample was run at 110 volts for 1 hour. 
 
The gel was placed under the UV transilluminator in order to identify and cut the 
insert and vector of interest for gel extraction and PCR clean up. 
 
 
2.9.7 Isolation of DNA from agarose gel electrophoresis 
 
 
The DNA band was cut out of the agarose gel and then weighed after placing in the 
Eppendorf tube. By using the QIAquick column the DNA of interest is isolated for 
further use in the process of DNA ligation. 
 
2.9.8 DNA ligation 
 
 
The extracted and purified DNA of the inserts and vector were ligated together in 
order to link the fragments and form a plasmid that contains the gene of interest. 
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2x ligase buffer 5 µL  
   
vector 2.25 µL (extracted & purified from 5 µL digested miniprep)  
   
insert 2.25 µL (extracted & purified from 5 µL digested miniprep or  
 digested & purified PCR )  
   
T4 DNA Ligase 0.5 µL  
   
Either overnight in the fridge or 2 hours at room temperature.  




Table 2: The process of ligation is summarised and clarified in the table above. 
 
 
2.9.9 Transformation of E Coli 
 
 
The competent cells were transformed by incubating 0.5 µL of this plasmid is put into 
50 µL of competent cells. The sample is then put on ice for 15 minutes, heat 
shocked for 1 minute at 42 °C and then placed on ice for two minutes. SOC medium  
(200 µL) is then added to the cells, which are then incubated at 37 °C in a water bath  
(no shaking) for 1 hour. Once the incubation time is over the sample is transferred 
onto LB-agar plate containing the following: Chloramphenicol at stock concentration 
of 34 mg/mL, Ampicillin at stock concentration of 100 mg/mL and glucose 20%.The 





In case of expressing genes that require BL21 star (DE3)plysS competent cells 
agar plate must contain Ampicillin at stock concentration of 100 mg/mL and glucose 
whereas the molecular biology samples require agar plate that contains Ampicillin 
at stock concentration of 100 mg/mL ,Chloramphenicol at stock concentration of 34 











High Performance Liquid Chromatography Mass spectrometry (HPLC-MS) allows 
applying the sample mixtures in a mobile phase by using the C 18 column. 
 
The sample is pumped with high pressure as it requires passing through a stationary 
phase that contains the packing material. This column is able to separate and 
categorise the components in the sample. 
 
The sample retention time is dependent on the interaction between the molecule of 
interest and the stationary phase, hence the samples that have the least interaction 
with the stationary phase will exit the column faster in comparison to other analytes 
that have different polarities and force of attraction to the stationary phase. As the 
components elute from the column, they are then introduced to a mass spectrometer 
by two interfaces known as the electrospray ionisation and the atmospheric pressure 



















































































































































































In the cobalamin biosynthetic pathway many enzymes tightly bind their products (Deery 
et al. 2012) [1], therefore it is hypothesized that some form of interaction between the 
enzyme-product bound and the following pathway enzyme must occur in order to 
release the intermediate and allow the biosynthesis to continue. In the following 
chapters, the function of CobH and CobB is investigated in order to observe the 
interaction using enzyme trapping methodologies and X-ray crystallography. 
 
3.0 HBA binding to CobB 
 
 
The purified substrate (HBA) was run on the UV visible spectrophotometer in order to 
measure absorbance at 328 nm and by using the extinction coefficient at 328 nm, 
the concentration of HBA can be calculated. The extinction coefficient value for this 
substrate is 50000 M-1 cm-1 and by following the following formula the concentration 
of purified HBA was calculated. The absorbance at 328 nm is around 0.349 as 
shown in figure 8. 
 
C= 計 / AL 
 
 
A = Absorbance (no unit) 
 
 Extinction coefficient = ܭ

 M-1 cm-1 
 
C = Concentration 

 units in M or mole / L 
 
L = Path length of 1 ml 






























































Figure 8: The purified HBA from RP18 column was examined by UV visible spectrophotometer in 
order to compare the spectra with the data that had been published in literature and make sure 




HBA, the product of CobH, is the substrate for CobB which amidates sidechains a and 
c to produce HBAD. At the early stage of project it is vital to observe how CobB 
behaves in presence of HBA in a mixture in order to observe the binding affinity of the 
substrate to the enzyme. The absorbance spectrum of the mixture clearly shows the 
close interaction of HBA and CobB spectra at 329 nm (figure 9). This spectra was 
taken at the initial stages of the experimenting CobB in order to become more familiar 






























































Figure 9: The interaction between HBA and CobB Alvin is shown as the spectra of HBA (orange) is 






3.1 Identifying the oligomeric state of CobB Alvin 
 
Gel filtration is a commonly used technique for determining the size and the 
molecular weight of the protein of interest in a more precise and wider range. In 
order to measure accurately, the oligomeric state of CobB is estimated by comparing 
the retention time with a known range of known protein standards as shown in 
calibration curve in figure 10. The CobB elution volume is at 15.5 mAU which 


































Figure 10 : the calibration curve is plotted by using the gel-phase distribution coefficient (Kav) 
versus the logarithm of the molecular weight (Log MW). The straight line is the calibration curve 
drawn from the data for obtaining the standard molecular weight (R2= 0.9926). This data is then 
used to determine the concentration of the CobB by comparing the highest elution peak with the 






























Figure 11: The elution volume of CobB is used to determine the oligomeric state of this enzyme. By 
comparing the value of the highest peak (15.50 mAU) with the standard protein range, it confirms 






The concentration of this protein is determined by taking a UV visible 
spectrophotometer read at 280 nm. The extinction coefficient of CobB is equal to 
27515 M-1 cm-1. This value is obtained from Protparam. Using the obtained values 
the final concentration of CobB can be determined. 
 
3.2 Thrombin cleavage of His-tag from CobB 
 
 
The main purpose of removing the His-tag from CobB is to aid crystallisation. This 
approach may also enhance the formation of crystals as the absence of His-tag 
enables the protein to fold more and rotate more freely. The labelled elution peak in 
figure 12 suggest that removal of His-tag has minor effect on the overall volume of 
the CobB when the His-tag is intact. This change is also noticeable as after the 
cleavage of the His-tag, the protein moves further down along the SDS-PAGE figure 
13 .This result provides an important evidence in terms of protein folding flexibilities 
































Figure 12 : After removing the His-tag from CobB, a slight changes in the elution volume is observed. 
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Figure 13 : The SDS-PAGE (A) is showing the CobB elution fractions that were collected during 
Nickel column and PD10 purification steps. The SDS-PAGE (B) is showing the non-His tagged CobB 
samples from FPLC elution fractions. The concentration of the protein in image B has reduced as the 
bands become fader and thinner in comparison to the image A. slight difference in the location of the 




3.3 Trapping HBA with His-tagged CobH Alvin 
 
The way of isolating CobH with its trapped product, HBA, is to express all the 
biosynthesis genes up to CobH including in one plasmid. 
 
All the genes necessary to produce precorrin-8 were overexpressed in E coli at the 
same time as overexpressing a His-tagged version of CobH. 
 
The resultant plasmid pET3a-AIGJFMKL-His-cobH contains all the genetic 
information to allow for the production of HBA as shown in figure 14. 
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Figure 14: The plasmid containing the genes encoding for the enzyme required for precorrin-8 was 
digested by EcoRI and SpeI endonuclease enzymes. Additionally, the plasmid containing the RBS 
His-tagged cobH Alvin was digested with EcoRI and XbaI. The two DNA fragments pET3a-
AIGJFMKLH and RBS His-CobH were then ligated together in order to generate a plasmid that could 
be used to produce both His-tagged CobH Alvin and precorrin-8 at the same time. 
 
 
3.3.1 Transformation, growth and purification of trapped CobH Alvin 
 
E. coli BL21 star (DE3) plysS competent cells were transformed with the pET3a-
AIGJFMKL-His cobH plasmid. The resulting recombinant strain carrying the plasmid 
was grown in the 2YT medium at 28 ºC for 24 hours and the overproduction of 





The bacteria were harvested by centrifugation and were subsequently resuspended 
in binding buffer composed of 20 mM Tris-HCl, pH 8.0, containing 100 mM NaCl and 
5 mM imidazole. 
 
After sonication to lyse the cells, the debris was separated from the soluble fraction 
by centrifugation. The soluble fraction was then applied to a chelating Sepharose 
charged with NiSO4 in order to purify the His-tagged CobH (abbreviated to His-CobH 
Alvin). The column was equilibrated with binding buffer (20 mM Tris-HCl, pH 8.0, 
containing 500 mM NaCl and 5 mM imidazole) and the unbound protein was washed 
with wash buffer I and II, which contain 50 mM and 100 mM imidazole respectively. 
 
The His-tagged protein was eluted from the column by application of elution buffer, 
which contains 500 mM imidazole. The His-tagged CobH protein was eluted as a 
pink protein as shown in Figure 15B, which indicated that the protein had product 
bound to it. The protein was then applied to a PD10 buffer exchange column that 
had previously been equilibrated with low salt buffer (20 mM Tris-HCl pH 8.0, 
containing 100 mM NaCl). The purification of the protein was followed by SDS-
PAGE, and the results are shown in Figure 16, which the purified protein showing a 
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Figure 15: Bacteria containing pET3aAIGJFMKL + His tagged cobH Alvin were grown in 2YT medium (A) 
and the His-CobH Alvin was purified through a Nickel column as shown in the image on the right (B). The 
elution fraction of His-CobH Alvin contained pink pigments, consistent with the presence of bound HBA. 
 
 

















































Figure 16: The collected fractions from each step of the purification were run analysed by SDS-PAGE. 
As shown on the image the trapped His-tag CobHAlvin runs with the expected molecular mass for this 









The results show that transformation of E.coli BL21 star (DE3) plysS with the pET3a-
AIGJFMKL-His-cobHAlvin has been successful as the purified His-CobHAlvin protein 
eluted with a pink colour. This suggests that the His-CobHAlvin is able to strongly 
bind its product, HBA. 
 
3.4 In vitro binding of CobH to HBA 
 
 
Previous studies have shown that the Rhodobacter capsulatus CobH also has a high 
binding affinity for its product HBA (Deery et al 2012) [1] (Thibaut et al. 1992) [6]. The 
binding interaction between HBA and CobH has been investigated in vitro previously 
by titrating enzyme into a known concertation of HBA. To determine the ratio of HBA 
that binds to His-CobHAlvin 1 mL of 4.2 µM HBA was pipetted into a cuvette and 5 µL 
of CobH Alvin, at a concentration of 5 µM, was added to the HBA solution. The 
absorbance readings were recorded on a UV visible spectrophotometer. This 
process involved the gradual and consecutive addition of 5 µL aliquots of His-
CobHAlvin into the cuvette containing HBA. This procedure was repeated until the 
enzyme was fully saturated with HBA as shown in Figure 17. 
 
This titration allowed observations in the changes of the HBA spectrum in response 
to increases in the concentration of CobH enzyme. The results showed that the UV 
visible spectrum of HBA is reduced as more protein is added. The absorbance 
values from 328 nm and 700 nm were selected in order to calculate the binding ratio 















Spectra showing the effect of increasing the concentration of CobH  
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Figure 17: The interaction between CobH and HBA is measured as the concentration of protein is 
increased. The curve shows that the in presence of CobH the HBA peak gradually decreases as the 





3.4.1 Binding ratio of CobH to its product HBA 
 
 
The UV visible spectroscopy data collected from the titration was plotted on a graph 
by selecting the readings taken at 328 nm in order to determine the binding ratio 
between CobH and HBA. The absorbance readings at 328 nm were selected 
because they showed the most significant change during the course of the titration. 









The graph clearly demonstrates that there is a relationship between the 
concentration of protein and the absorbance of HBA at 328 nm. 
 
The lines drawn on the graph indicate the point of saturation, where the HBA is fully 
bound to the protein. The data show that when the concentration of protein is around 
8 µM which indicates that the protein is a dimer interacts with 4.2 µM of HBA. The 
obtained values suggest that the binding ratio of CobH to HBA is 2:1, which suggest 
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Figure 18: The binding ratio of HBA to enzyme (CobH Alvin) is estimated at the point where the line 
flattens. This corresponds to the point of saturation where 4.2 µM HBA is bound completely by CobH. 
From reading this point on the X-axis it shows that the concentration of CobH is around 8 µM. 














By undertaking a titration of HBA with purified CobH Alvin it was possible to 
determine the ratio of product that binds to the enzyme. The binding ratio of the 
CobH to the HBA was found to be similar to what had been observed previously and 
reported in the literature (Thibaut et al. 1992) [6] , which is 2:1 ratio. 
 
CobH is known to be a homodimeric enzyme (Warren et al. 2002) [2]. The results 
here indicate that one molecule of HBA binds per dimer of protein. 
 
Although the protein is known to have two active sites per dimer it is clear from this 
titration that only one site is occupied per dimer. This suggests that there is some 
gating mechanism whereby when one site is occupied the other site becomes closed 
so as not to allow another HBA molecule to bind. It is not immediately obvious why 
this should be so, but it does suggest that the enzyme has regulatory mechanism in 
place in order to limit the activity of the enzyme. Alternatively, the dimer may be able 
to bind two molecules of product, but the second site must have a very low affinity for 
HBA. 
 
3.5 Trapping HBA/ HBAD with the His tagged CobB Alvin 
 
Constructing a His-CobB Alvin trapping plasmid involved cloning the inserts from pET3a-
AIGJFMKLH and pET14b-cobB Alvin together in order to express a non His-tagged 
CobH and a His-tagged CobB Alvin at the same time, as outlined in Figure 15. To 
achieve this, the pET14b-His-cobBAlvin plasmid was cut with the restriction enzymes 
XbaI and EcoRI to generate the insert His-cobB Alvin .The pET3a-AIGJFMKLH plasmid 
was cut with restriction enzymes XbaI and SpeI and then the His-cobB Alvin insert was 








The cloned plasmid has the ability to produce both HBAD as well as a His-tagged 
 
version of CobB Alvin as shown in figure 19. 
 








































Figure 19: The plasmid containing genes encoding the enzymes for precorrin-8 production and CobH 
was digested by XbaI and SpeI restriction endonucleases. Additionally, the plasmid containing His-
tagged-CobBAlvin was digested with EcoRI and XbaI. The two fragments are ligated together in order 























E. coli BL21 cells containing pLysS were transformed with pET3a-AIGJFMKLH-His-
cobBAlvin. The resultant strain was then grown in order to determine if a product-
trapped version of CobB could be purified. The trapped His-CobBAlvin was purified 
following the same procedures as described for purification of the trapped His-
CobHAlvin as described in Section 2.4. The trapped His-CobBAlvin eluted with a 
pink/orange colour, as shown in Figure 20. The purification of the protein was 
followed by SDS-PAGE, where the purified protein was found to migrate with a 





























Figure 20: The pellet of the CobB-trapping strain and the purified His-CobBAlvin.The pET3a-


































































































Figure 21: The fractions at each stage of the purification of the His-CobBAlvin were run on an SDS-
PAGE. The molecular mass of the trapped His-CobBAlvin is 48 kDa, which is consistent with its gene-





The colonies obtained from the transformation of E. coli BL21 star (DE3) pLysS with 
the cobB-trapping plasmid were grown in 2YT medium. The pink colour of the 
bacterial pellet was an indication that the plasmid was producing a corrin of some 
description, as this is the colour of HBA/HBAD. The purified protein eluted with a 
strong pink colour, which could be either HBA/HBAD, as the spectra of HBA/HBAD 
have identical UV visible spectra. The His-CobBAlvin was therefore purifying with a 
bound material that was likely to be either is substrate of its product. This pink 







3.6 Identifying the spectrometry of coloured pigment by HPLC- MS 
 
 
A sample of purified His-CobB Alvin obtained after nickel affinity column purification 
(Figure 20 B) was heated to 80 ºC in order to denature the protein and release the 
bound pigment from it. This released pigment was then analysed by HPLC-MS in order 





































Figure 22: Pigment analysis of the purified His-CobBAlvin. As shown in the trace above, HBAD is the 
most abundant product of the enzyme trapping experiment. However, other peaks are present which 
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Figure 23: The HPLC MS showing the absorbance at 328 nm after 22.9 minutes. The number (m/z) 880 
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Figure 24: The HPLC MS trace showing an absorbance at 328 nm after 25.2 minutes. The number 
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Figure 25: The HPLC MS showing an absorbance at 328 nm after 19.8 minutes. The number (m/z) 879 
 

























HPLC analysis reveals that His-CobBAlvin is able to bind its substrate HBA, HBA 
monoamide as well as its major product HBAD. The major pigment bound to the 








The purified trapped His-CobBAlvin was a pink colour. In order to identify the 
tetrapyrole bound to the His-CobBAlvin the pigment was extracted and run on a MS-
HPLC system. The resulting chromatograms showed that CobB binds HBAD, HBA-





3.7 In vitro binding of His-CobB Alvin  to HBA and HBAD 
 
The in vitro binding of His-Cob Alvin to HBA or HBAD was investigated by varying the 
concentration of His-CobBAlvin (0, 2.5 µM, 5 µM, 7.5 µM, 10 µM and15 µM) to a fixed 
concentration of HBA or HBAD, during which the UV-vis spectrum was recorded. 
The aim of this titration was to see how the presence of CobB could modify the 


















































Spectra showing the effect of increasing the concentration of His-  
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Figure 26: Spectra showing the UV-vis absorbance readings from 300 nm to 700 nm in which the 
concentration of HBA was kept constant and the concentration of His-CobBAlvin varied from 0, 2.5, 5, 
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Figure 27: Spectra showing the absorbance readings from 300 nm to 700nm during a His-CobBAlvin 
titration with HBAD. The concentration of HBAD was kept constant and the concentration of His-





The modification to the HBA and HBAD spectra when His-CobBAlvin was titrated was 
not conclusive in that it was difficult to observe a saturation point. This is could be 
due to a number of reasons, including pipetting errors or uneven mixing of the 
protein to HBA or HBAD. Due to time restrictions this experiment was not repeated. 
Nonetheless, the fact that clear changes in the spectrum were observed suggested 










3.8 In vitro binding of His-CobB Alvin  to CobH-HBA 
 
Another method regarding the in vitro binding of CobB to HBA was undertaken by 
using Native-PAGE and SDS-PAGE. In this experiment, His-CobBAlvin was added to 
the bound complex of CobH-HBA. The reason for carrying this test was to 
investigate if CobB was able to release the HBA from CobH, as would be expected if 
direct metabolite transfer was in operation. 
 
To a fixed concentration of CobH-HBA variable concentrations of His-CobBAlvin (0, 
2.5, 3.75, 5, 6.25, 7.5, 8.75, 10, 12.5 and15 µM) were added. This test also required 
a number of controls including non-mixed samples for CobB and CobH-HBA. 
 
The interaction between the two enzymes was observed when they were run on the 
Native-PAGE as shown in Figure 28. CobH with bound HBA and apo CobH migrate 










































































































Figure 28: The Native-PAGE gel shows the un-denatured mixture of CobH Alvin -HBA + CobB Alvin in order 
to determine whether HBA has been released from CobH. This would result in uptake of this product 
by His –CobB Alvin varied from 2.5 µM (A), 3.75 µM (B), 5 µM (C), 6.25 µM (D), 7.5 µM (E), 8.75 µM 
(F), 10 µM (G), 12.5 µM (H) and15 µM (I) 
 
The same procedure towards preparing the samples was used for the denaturing gel 
SDS-PAGE. The CobB concentrations of 0, 2.5, 3.75, 5, 6.25, 7.5, 8.75, 10, 12.5 and 
15 µM were mixed with a constant concentration of CobH-HBA (5.8 mg/mL) and 























































































Figure 29: The SDS-PAGE gel showing the denatured mixture of CobHAlvin HBA + CobBAlvin in order to 
 
confirm the presence of both CobH and CobB, with increasing concentration of CobB. 2.5 µM (A), 





The results from both the Native PAGE (Figure 28) and the SDS-PAGE (Figure 29) 
did not show strong signs of interaction between protein and the substrate. The weak 
interaction in both cases suggests that no complex is made between CobH-HBA and 
CobB. However, as the protein bands were still present, it could mean that the 
concentration of CobH-HBA was too low hence the possibility of interaction with 
CobB was reduced. Moreover, the gel suggest that a certain amount of proteolysis 
has taken place, as both CobH and CobB ran as multiple bands. This investigation 










3.9 Crystallography of CobH/ CobB Alvin  in presence and absence of HBA 
 
The process of identifying structural properties of macromolecules via X-ray 
crystallography involves a multistep procedure that includes choosing a suitable 
target molecule, cloning, purifying and crystallising the pure soluble protein. The 
protein needs to be crystallised under conditions that allow the protein to fall out of 
solution in a controlled and ordered fashion. These conditions may alter if substrates 
are also present. 
 
Crystallography provides an opportunity to learn more about the active site of the 
enzyme and the binding site of the substrate in molecular detail. Kits from Molecular 
Dimensions, screens 1 and 2 were used to investigate conditions for crystallisation of 
both CobB and CobH through the method known as hanging drop vapour diffusion. 
In this method the drop containing the protein, its product and the reagent are 
equilibrated with the liquid reservoir. 
 
When the concentration of buffer in the drop and the reservoir reaches equilibrium 
the concentration of precipitant and protein increases in the drop and should the 
protein be in an appropriate crystallisation buffer, crystal growth will occur in the 
drop. The condition of interest that sustains crystal growth is subtly altered by screen 
optimisation that involves changing the concentration of chemicals that were in the 
condition. The screen conditions are designed by using the Hampton research tray 
maker program which allows inserting a different range of variable values. The 
following favourable conditions that allowed CobB protein to crystallise is as follow: 
Condition: MD1-01 tube 23 0.2 M Calcium chloride dihydrate (0, 0.1, 0.2, 0.3) 0.1 M 









The pH of the solution is constant using appropriate buffer. However, other factors 
such as the percentage of PEG400 and the concentration of calcium chloride 
dihydrate were changed in respect to the volume from the original screen. The total 
volume of 500 µL is achieved by addition of water to the mixture as shown in table 3. 
 
0 M CaCl2 0.1 M CaCl2 0.2 M CaCl2 0.3 M CaCl2 
22 % PEG 400 22 % PEG 400 22 % PEG 400 22 % PEG 400 
0.1  M HEPES pH7.5 0.1  M HEPES pH7.5 0.1  M HEPES pH7.5 0.1  M HEPES pH7.5 
    
0 M CaCl2 0.1 M CaCl2 0.2 M CaCl2 0.3 M CaCl2 
24 % PEG 400 24 % PEG 400 24 % PEG 400 24 % PEG 400 
0.1  M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 
    
0 M CaCl2 0.1 M CaCl2 0.2 M CaCl2 0.3 M CaCl2 
26 % PEG 400 26 % PEG 400 26 % PEG 400 26 % PEG 400 
0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 
    
0 M CaCl2 0.1 M CaCl2 0.2 M CaCl2 0.3 M CaCl2 
28 % PEG 400 28 % PEG 400 28 % PEG 400 28 % PEG 400 
0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 
    
0 M CaCl2 0.1 M CaCl2 0.2 M CaCl2 0.3 M CaCl2 
30 % PEG 400 30 % PEG 400 30 % PEG 400 30 % PEG 400 
0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 
    
0 M CaCl2 0.1 M CaCl2 0.2 M CaCl2 0.3 M CaCl2 
32 % PEG 400 32 % PEG 400 32 % PEG 400 32 % PEG 400 
0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 0.1 M HEPES pH7.5 
    
 
 
Table 3: The condition of which the crystal growth took place is closely examined by screening around 
the variables that made up the condition. The Hampton research tray design has allowed calculating 
the volume of essential ingredients required for each well so the accuracy of the measurements is 
ensured before the experiment was carried out. The volume of CaCl2 is varied from 0 M-0.3 M, 




The tray was kept at 18 °C and the percentage of precipitants were examined 1 hour 
after placing the tray. The following examination of the precipitant took place 3 days 
later in order to allow the process of crystallisation to complete. The crystal samples 
picked from condition with higher percentage of PEG 400 mostly contained a sticky 





The skin traps the crystal inside the drop hence it becomes difficult to get hold of the 
crystal or due to the several attempts the crystal can break or get dissolved in the 
solution of drop. PEG is known to act as a protective factor in crystallography but it 
can also be considered as a disadvantage when its concentration exceeds a certain 
percentage. 
 
For this reason the crystals that were found in lower percentage of PEG 400 were 
collected for X-ray diffraction examination. Other factors such as lower concentration 
of calcium chloride dihydrate seemed to have least effect on the quality and quantity 
of the crystals hence the picked samples were selected from 0.2 and 0.3 M CaCl2. 
 
Another set of screening was performed for the following condition in which the 
CobB protein crystallised in presence of its substrate HBA. 
 
MD1-02 tube 8: 0.2 M Ammonium phosphate monobasic (NH 4)3 PO4, 0.1 M Tris, 
 
pH 8.5, 50 % v/v MPD (highlighted in table 4) 
 
 
The concentration of each chemical that made up this condition was varied in order 
to enhance the chances of obtaining crystals therefore for this reason two separate 
screens were set up. In order to see the effect of change in pH and (NH4)3 PO4 
concentration, the pH ranged between 8.1-8.5 and (NH4)3 PO4 ranged from 0.14 M 



















































Table 4: CobB bound HBA protein crystal was obtained from the condition containing 0.2 M (NH4)3 
PO4, 0.1 M Tris, pH 8.5, 50 % v/v MPD which is highlighted in pink. The optimization includes 
changing the (NH4)3 PO4 concentration shown on the x-axis of the table and the pH of Tris as shown 





The second optimised screen was focused on changing the percentage of MPD at 
different pH of Tris while the (NH4)3 PO4 concentration is kept constant (table5). As 
shown in table 6, the crystals picked from the suitable condition and frozen so the 
sample is pryo-protected for X-ray analysis in order to determine the structure of 














































Table 5: the optimised screen based on variables such as MPD % (30%-70%) and Tris-pH (8.1-8.7). 
 
































Table 6: the cob-HBA crystals from the optimised screen were selected and picked from the 











3.9.1 Crystallising CobH Alvin  +/- HBA 
 
In order to crystallise CobHAlvin in presence of its substrate HBA, the concentration 
of protein Cob Alvin was measured at 280nm giving a value around 6 mg/mL and the 
concentration of HBA at 328 nm was determined to be 5 mg/mL. For crystallography 
screens HBA was added to the protein in a ratio of 5:1. 
 
The protein formed crystals in the following condition: 
 
 
CobHAlvin without HBA crystals: 
 
2M Sodium-acetate Trihydrate, 0.1 M Imidazole pH 6.5 
 
 
CobHAlvin  + HBA crystals (figure 30): 
 
0.2 M Sodium-citrate tribasic dihydrate, 0.1 M Tris pH8.5, 30 % v/v PEG 400 
 
 
The optimisation of these conditions is still under investigation as this experiment 
























Figure 30: By using the crystallisation structure screens 1 and 2 provided by Molecular Dimensions, 
 










3.9.2 Crystallising CobB Alvin  +/- HBA and HBAD 
 
CobBAlvin was also tested using the Molecular Dimension screening kits. 
 
The initial attempt towards crystallising CobBAlvin was done in presence and 
absence of HBA. A significant amount of precipitation was seen due to the high 
concentration of the protein. Hence in the subsequent attempts the concentration of 
protein was reduced. Favourable conditions that generated crystals were optimised 
by further screening around these conditions. The resultant crystals were sent for X-
ray diffraction analysis. Disappointingly, the results from the X-ray crystallography 
indicated that the crystals were formed from salt and not protein. 
 
Further attempts to crystallise the protein were undertaken in order to find alternative 
conditions, which included the addition of coenzymes such as ATP, non-
hydrolysable ATP, glutamine and Mg2+. Each of the named coenzymes and 
substrates can enhance crystal development by increasing the stability of enzyme. 
 
Depending on the total concentration of the purified protein, the addition of ATP (5x) 
and Mg2+ (10x) excess was required. As mentioned before, the ratio of 5:1 HBA to 
protein was added to the conditions where the protein and its substrate were in the 
drop. The optimised screens showed an increase in the number of crystals in 















































   
 
 
Figure 31: Figure A shows the crystals in a condition where protein (CobB) and substrate (HBA) 
were in the mixture drop. Figure B shows a crystal of CobB on its own. The shape of the protein 
crystal changed with the addition of additives such as ATP, Mg2+ and glutamine. 
 
 
The presence of heavy precipitates in conditions where the substrate was included in 
the mixture suggested that further improvements were required to enhance 
crystallisation. The His-tag on the protein also has the potential to interfere with the 
crystallisation process. Hence, the N-terminus His-tag of the protein was removed by 
thrombin cleavage. 
 
The His-tag free protein drops contained the least precipitate and the crystals were 
found to have smoother surfaces and edges in comparison to the crystals that were 
obtained before removing the His-tag. However, CobB did not seem to interact with 











Temperature is a significant variable in the crystallisation of macromolecules as it 
influences nucleation and crystal growth by controlling the solubility and supersaturation 
of the sample. For this reason, another approach aimed at reducing the rate of 
precipitation in the drop was undertaken by lowering the temperature in which the crystal 
was set and stored. This resulted in the formation of smaller crystals in comparison to 
the crystals that were grown at room temperature. However, a significant reduction in 
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Figure 32: Both figures A and B show crystals of CobB in the presence of HBA in the mixture. The 
screen was set and stored at lower temperature and this factor has affected the rate of growth, 
size and shape of the crystals. 
 
The X-ray crystallography results showed that due to the unstable conformation of 
the protein crystals it was not possible to see a diffraction pattern when the crystals 
were placed in the X-ray beam (Figure 31 and 32). Since methods such as His-tag 
cleavage and reduction in temperature did not result in crystallisation of the protein 
of interest, future screens need to be carried out . 
 
The addition of certain chemicals that affect hydration and intermolecular interactions 
between protein molecules or protein molecules and solvent, and even ligands, may 















The CobB protein crystals were picked from the following optimised condition: 
 
 
MD1-02 condition 23 
 
 
1.6 M Ammonium sulphate 
 
 
0.1 M MES 6.5 
 
 
10 % v/v 1,4-Dioxane 
 
 
In order to optimise this condition, the concentration of certain chemicals that made 
up the buffer of interest were changed. For instance, the crystal required 1.6 M 
ammonium sulphate but for the purpose of optimisation, this concentration was 
varied from 1 to 2 M. The pH of 0.1 M MES was kept constant because changes in 
pH could result in the formation of a heavy precipitate. Lastly, the concentration of 1, 
4-Dioxane was varied from 6 -12 %. 
 
As shown in Figure 33(A) the CobB drops are at the stage known as phase 
separation, which likely represents a metastable transition where protein crystals 
may form. Hence the condition was optimised as shown in Figure 33(B). At the final 
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Figure 33: The CobB crystal formed in condition 23 of structure screen 1. The original condition (A) is 






The results have shown that it is possible to crystallise the CobB protein both in the 
absence and presence of HBA. Unfortunately, the crystals that have been obtained 


















































































































Discussion and Conclusion 
 
 
This report describes attempts to understand how metabolites are passed between 
enzymes within the cobalamin (vitamin B12) biosynthetic pathway. Of the thirty 
enzymes linked with cobalamin biosynthesis this investigation has focussed on the 
potential interaction between CobH and CobB. Specifically, the project has looked at 
these enzymes from A. vinosum, as preliminary research on the A. vinosum CobB 
had shown that this enzyme is more active and more stable than previously studied 
enzymes. The method of communication between CobH and CobB relates to the 
transfer of HBA, which is the product of the reaction that is catalysed by CobH. 
Previous publications had provided convincing evidence that there is a tight 
interaction between CobH and HBA (Thibaut et al. 1992) (Deery et al. 2012). Indeed, 
characterisation of the A. vinosum CobH also showed that this protein is able to bind 
HBA tightly, revealing a ratio of one HBA bound per CobH dimer. The fact that the A. 
vinosum His-CobH purifies from a HBA-producing strain with bound HBA indicates 
the strength of the interaction. 
 
Additionally, the sequence comparison between the solved 3D-structure of 
Rodobacter capsulatus CobH-HBA and Alvin-CobH which is provided at the end of 
this chapter shows the regions of similarity between the two sequences. This 
comparison shows an indication of functional and structural relationship that exists 
between the named bacterial strains. This level of similarity and identity could also 
mean that crystallising the CobHAlvin can be made possible. 
 
The key question underlying this research project is, given that CobH binds HBA so 
tightly, how CobB recognises the product of CobH and how this product (HBA) is 







enzyme in the pathway, CobB, would lead to a conformational change and the release 
of the product to allow it to bind to CobB. In this respect it can be thought that the 
interaction between CobH and CobB would weaken the interaction between CobH and 
HBA, allowing the released intermediate to bind with CobB. To investigate this further a 
number of experiments were undertaken with a view to gaining some insight into the 
interaction between CobH and CobB. These experimental approaches included attempts 
to look at the release of HBA by native gel electrophoresis and the crystallisation of both 
enzymes. The latter approach would provide the necessary molecular detail to 
determine if the proteins were able to interact with each other. 
 
As mentioned above, it was possible to demonstrate that the A. vinosum His-CobH is 
able to bind HBA in a HBA-producing strain. This enzyme-trap approach allows for 
the isolation of large amounts of HBA-bound CobH. Using a similar enzyme-trap 
approach it was also possible to show that the A. vinosum His-CobB also could be 
purified with a bound pigment. However, with CobB was not clear whether the 
extracted enzyme had bound its substrate or its product. Thus the pigment bound to 
CobB was released after the protein was denatured and the material analysed by 
HPLC-MS. This revealed that CobB had bound HBAD, HBA and HBA monoamide. 
However, the major component isolated in this study was HBAD, suggesting that 
CobB also holds onto its product tightly. 
 
Returning to the question of how CobB get hold of its product from CobH, we sought 
to devise a way to follow the release of HBA from CobH in the presence of CobB. 
One idea was to try and follow this process by using Native PAGE. Previous 
research had shown that CobH runs differently on a native gel to CobH with bound 
HBA. We therefore though that it may be possible to follow the release of HBA from 






CobB. Similarly, it may be that CobB would also show a differential migration in the 
presence of a bound substrate. However, when this gel shift analysis was 
undertaken there was no apparent shift in either CobH or CobB. However, both 
proteins showed some evidence of degradation indicating that the proteins were 
perhaps not as stable as previously thought. However, the experimental approach 
also really needs to be done again in the presence of substrate and other 
cofactors including ATP and glutamine as the absence of these may have 
contributed to the instability of CobH and CobB. 
 
Obtaining crystal structures of both CobH and CobB would improve our 
understanding of the binding sites of the enzymes of interest. Ideally, a structure of a 
CobH/CobB complex would provide unprecedented insights into how these proteins 
interact. As a start to this overall aim protein crystallography was undertaken on the 
individual enzymes, CobH and CobH. Attempts were made to gain crystals of these 
enzymes in the presence and absence of HBA, as well as the other substrates 
associated with the CobB enzyme. A wide range of conditions were explored, mainly 
using the kits available from Molecular Dimensions. Removal of the His-tag was also 
explored as a way to try and grow improved crystals. However, despite the wide 
range of conditions that were explored, no diffraction quality crystals were obtained. 
 
Bioinformatics analysis of CobB performed by others suggests that the protein is 
composed of two domains, representing a domain that releases ammonia from 
glutamine and a domain that amidates the carboxylic acid side chain of HBA. Movement 
between these domains may mean that the protein is quite flexible and this flexibility 
may prevent the formation of suitable crystals. Therefore, future work may have to 








will be used to bind the substrate without catalysing the reaction in a more static 
conformation. 
 
In conclusion, although it has been possible to crystallise CobH and CobB diffraction 
quality crystals still need to be formed, a process that requires more time. CobH 
binds HBA very tightly but this does not prevent the interaction between CobH-HBA 
and CobB. CobB also binds its product very tightly. All of this provides further 
evidence that the B12 biosynthetic enzymes must work by substrate channelling. 
 
Sequence comparison between the solved 3D-structure of Rhodobacter 
 





Identity: 126/210 (60.0%) 
 
Similarity: 154/210 (73.3%) 
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